Items tagged with Treatment
New biomarker identified for predicting adverse events of TB therapy (post)
Borstel researchers are the first to develop a biomarker to predict the occurrence of neuropathic adverse events during therapy for multidrug-resistant tuberculosis. The results have now been published in the journal Pathogens & Immunity.
Johnson & Johnson agrees to lower price of TB drug bedaquiline, allow production in South Africa (post)
South Africa's anti-trust regulator announced on July 5 that drugmaker Johnson & Johnson (J&J) and its subsidiary, Janssen Pharmaceutical, have agreed to withdraw a secondary patent on the tuberculosis (TB) drug bedaquiline.
Johnson & Johnson's patent for paediatric TB drug rejected in India, move hailed as 'significant victory' for children (post)
New Delhi: In a big victory for TB activism and children suffering from TB in India, the country’s patent office rejected Johnson & Johnson’s (J&J) patent application for the paediatric formulation of Bedaquiline on Friday, July 5.
NIH funds consortium to speed TB treatment development (post)
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis (TB).
Better, shorter TB treatments are available. Why aren’t more people receiving them? (post)
TB activists co-founded the 1/4/6×24 Campaign to demand the universal implementation of shorter and more effective TB regimens: as little as one month or once weekly for TB prevention, four months for drug-sensitive TB, and six months for drug-resistant TB by the end of 2024.
High risk for TB recurrence, mortality during treatment with tobacco use (post)
Patients with tuberculosis who used tobacco faced a heightened risk for disease recurrence/relapse and death during treatment, according to a systematic review and meta-analysis published in CHEST.
Request for proposals: Fast Track the Cure: Community engagement and awareness building for new DR-TB treatments (post)
The TB Alliance Fast Track the Cure initiative launched a Request for proposals (RFP): Fast Track the Cure: Community engagement and awareness building for new drug-resistant TB (DR-TB) treatments.
‘I wasn’t sure I’d make it’: how a new mother’s brush with TB could mean better treatment for pregnant women (post)
When she was pregnant with her second child, Busisiwe Beko was living with HIV, but that didn’t worry her. She had been taking antiretrovirals for years and as an experienced Aids activist in South Africa she knew that as long as she continued to take her pills every day, her second baby would be born free of infection, just like her first.
Research on the treatment of rifampin-susceptible TB: Time for a new approach (post)
Despite 25 years of clinical trials, there has been only modest progress in improving treatment of rifampin-susceptible TB.
Kanamycin (post with image)
Kanamycin Sulphate (Km)
Page 76 of 108 · Total posts: 0
←First 75 76 77 Last→